
AI-designed drugs are entering clinical trials, and 2026 is the year we learn if they actually work
AI has already proven it can speed up drug discovery. What it hasn't proven is that AI-designed molecules perform better in patients — and 2026's Phase 2 and 3 readouts are the first large-scale test.










